Pharmaceuticals and Healthcare Reports Private Equity and Venture Capital Funding for Hea

2,5-Second Bromotoluene ( CAS 615-59-8 ) Market Size , Share , Growth , Cost and Price , Analysis , Key Trends and Opportunities Forecasts 2016

2,5-Second Bromotoluene ( CAS 615-59-8 ) Market Size , Share , Growth , Cost and Price , Analysis , Key Trends and Opportunities Forecasts 2016

Summary GBI Research ’ s latest report , "" Strategic Trends in Private Equity and Venture Capital Funding for Healthcare "" provides a comprehensive analysis on emerging investment trends within the healthcare industry . Private equity ( PE ) and venture capital ( VC ) funds have been important participants in a wide range of industries for many decades - particularly the healthcare industry . They remain one of the few sources of funding for innovative startup companies , which often bring disruptive technologies and life-saving medical interventions to the market .
This report provides in-depth qualitative and quantitative analyses of global and regional trends that have shaped the current healthcare PE and VC landscape , particularly from 2006 to 2015 . It provides multilevel analyses that identify geographical markets and therapy areas attracting noteworthy investments . Analyses of key investment indicators in the US , including levels of fundraising activities by PE and VC companies , VC investments by industry sector , and VC-backed exits and venture financing trends - particularly for early-stage healthcare companies - are also included .
Read Complete Report with TOC @ http :// www . radiantinsights . com / research / strategic-trends-in-privateequity-and-venture-capital-funding-for-healthcare
Information from our robust , industry-leading databases shows that global values of completed equity offerings in the healthcare industry are continuing their upward trend , reaching record highs in recent years . Quantitative analyses of equity offerings in the healthcare sector from 2006 to 2015 are provided alongside trends in healthcare VC-backed initial public offerings ( IPOs ) in the US . Top healthcare IPOs are reviewed in detail , with company profiles that include product pipelines showing therapy areas of focus , indications and product development stages .
The report also includes forecasts for the outlook for PE and VC firms investing in the healthcare sector . VC investment in early-stage healthcare companies continues to decline , and has almost completely disappeared in certain countries . The report discusses new financing models that are emerging and replacing traditional VC financing models , including case studies showcasing recent success stories .
GBI Research conducted extensive research in order to provide a comprehensive view of the strategic trends in PE and VC funding for healthcare .
This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising areas in the market and exploit key business opportunities .